Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares, $0.00001 Par Value
-
Shares outstanding
-
494M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
692K
-
Shares change
-
+638K
-
Total reported value, excl. options
-
$11.8M
-
Value change
-
+$10.8M
-
Number of buys
-
13
-
Number of sells
-
-2
-
Price
-
$17.04
Significant Holders of Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC) as of Q2 2025
16 filings reported holding RGC - Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value as of Q2 2025.
Regencell Bioscience Holdings Ltd - Ordinary Shares, $0.00001 Par Value (RGC) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 692K shares
of 494M outstanding shares and own 0.14% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (391K shares), Squarepoint Ops LLC (99.8K shares), Schonfeld Strategic Advisors LLC (52.1K shares), BNP PARIBAS FINANCIAL MARKETS (45.1K shares), UBS Group AG (37.5K shares), MORGAN STANLEY (33K shares), Y-Intercept (Hong Kong) Ltd (13K shares), Greenfield Savings Bank (11K shares), BlackRock, Inc. (8.59K shares), and OSAIC HOLDINGS, INC. (190 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.